IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes - PubMed (original) (raw)
IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes
M Hurme et al. Eur J Immunol. 1998 Aug.
Free article
Abstract
The genes in the IL-1 complex code for three proteins, IL-1alpha, IL-1beta and the IL-1 receptor antagonist (IL-1 Ra). The severity of a given infection is influenced by the balance between the levels of IL-1beta, the major extracellular agonist, and that of IL-1 Ra. In healthy individuals, IL-1 Ra is readily detectable in plasma but IL-1beta levels are usually undetectable. As there are polymorphisms in both of these genes, we have now analyzed whether there are allelic associations between these loci and whether these would have an influence on plasma IL-1 Ra levels. In 200 healthy blood donors, the mean plasma IL-1 Ra concentration was 681 pg/ ml. The IL-1Ra allele 2 (IL1RN*2) had a clear influence on IL-1Ra levels: its carriers had higher levels than the non-carriers (745 ng/ml vs. 627 pg/ml, p < 0.05, t-test). As marker alleles for IL-1beta we used two biallelic base-exchange polymorphisms (at positions -511 and +3953 relative to the transcriptional start site). The more rare allele of IL-1beta -511 (allele 2) was significantly associated with the presence of IL-1 Ra allele 2, but in the case of the IL-1beta +3953, the more rare allele (allele 2) was less frequent in the carriers of the IL-1 Ra allele 2. These IL-1beta allelisms did not have a direct influence on plasma IL-1Ra levels, but the enhancing effect of IL-1 Ra allele 2 on IL-1 Ra plasma levels required the presence of the IL-1beta -511 allele 2 or absence of the IL-1beta +3953 allele 2. Taken together, these results indicate that the IL-1beta gene participates in the regulation of IL-1 Ra production in vivo and that the alleles of IL-1beta and IL-1 Ra which demonstrate this cooperative effect are often associated.
Similar articles
- Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro.
Santtila S, Savinainen K, Hurme M. Santtila S, et al. Scand J Immunol. 1998 Mar;47(3):195-8. doi: 10.1046/j.1365-3083.1998.00300.x. Scand J Immunol. 1998. PMID: 9519856 - IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy.
Tolusso B, Pietrapertosa D, Morelli A, De Santis M, Gremese E, Farina G, Carniello SG, Del Frate M, Ferraccioli G. Tolusso B, et al. Pharmacogenomics. 2006 Jul;7(5):683-95. doi: 10.2217/14622416.7.5.683. Pharmacogenomics. 2006. PMID: 16886894 - IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels.
Buchs N, di Giovine FS, Silvestri T, Vannier E, Duff GW, Miossec P. Buchs N, et al. Genes Immun. 2001 Jun;2(4):222-8. doi: 10.1038/sj.gene.6363766. Genes Immun. 2001. PMID: 11477478 - Polymorphism of IL-1 receptor antagonist gene: role in cancer.
Sehouli J, Mustea A, Könsgen D, Katsares I, Lichtenegger W. Sehouli J, et al. Anticancer Res. 2002 Nov-Dec;22(6A):3421-4. Anticancer Res. 2002. PMID: 12530098 Review. - The balance between IL-1 and IL-1Ra in disease.
Arend WP. Arend WP. Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):323-40. doi: 10.1016/s1359-6101(02)00020-5. Cytokine Growth Factor Rev. 2002. PMID: 12220547 Review.
Cited by
- Interleukin-1 gene cluster variants in hemodialysis patients with end stage renal disease: An association and meta-analysis.
Tripathi G, Rangaswamy D, Borkar M, Prasad N, Sharma RK, Sankhwar SN, Agrawal S. Tripathi G, et al. Indian J Nephrol. 2015 Jan-Feb;25(1):34-42. doi: 10.4103/0971-4065.135350. Indian J Nephrol. 2015. PMID: 25684870 Free PMC article. - Genetic influence of cytokine polymorphisms on the clinical outcome of Japanese gastrointestinal cancer patients in palliative care.
Hishida A, Okugawa Y, Morimoto Y, Shirai Y, Okamoto K, Momokita S, Ogawa A, Tanaka K, Nishikawa R, Toiyama Y, Inoue Y, Sakurai H, Urata H, Tanaka M, McMillan DC, Miki C. Hishida A, et al. Oncol Lett. 2019 Jan;17(1):623-629. doi: 10.3892/ol.2018.9614. Epub 2018 Oct 24. Oncol Lett. 2019. PMID: 30655809 Free PMC article. - Investigation of the role of interleukin-1 receptor antagonist VNTR variant on the Behçet's disease.
Dursun G, Nursal AF, Demir HD, Karakuş N, Demir O, Yiğit S. Dursun G, et al. Eur J Rheumatol. 2018 Mar;5(1):27-31. doi: 10.5152/eurjrheum.2017.16102. Epub 2017 Oct 25. Eur J Rheumatol. 2018. PMID: 29657871 Free PMC article. - Prediction of sepsis-related outcomes in neonates through systematic genotyping of polymorphisms in genes for innate immunity and inflammation: a narrative review and critical perspective.
Carvalho JK, Moore DB, Luz RA, Xavier-Elsas PP, Gaspar-Elsas MI. Carvalho JK, et al. Sao Paulo Med J. 2013;131(5):338-50. doi: 10.1590/1516-3180.2013.1315519. Sao Paulo Med J. 2013. PMID: 24310803 Free PMC article. Review. - Interleukin-1 Receptor Antagonist and Interleukin-4 Genes Variable Number Tandem Repeats Are Associated with Adiposity in Malaysian Subjects.
Kok YY, Ong HH, Say YH. Kok YY, et al. J Obes. 2017;2017:4104137. doi: 10.1155/2017/4104137. Epub 2017 Feb 15. J Obes. 2017. PMID: 28293435 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials